Barclays (LON:BARC) analyst Steven Valiquette maintained a Buy rating on Cigna Corp on Monday, setting a price target of $290, which is approximately 8.65% above the present share price of $266.91.
Valiquette expects Cigna Corp to post earnings per share (EPS) of $11.40 for the second quarter of 2021.
The current consensus among 13 TipRanks analysts is for a Strong Buy rating of shares in Cigna, with an average price target of $290.92.
The analysts price targets range from a high of $320 to a low of $230.
In its latest earnings report, released on 12/31/2020, the company reported a quarterly revenue of $41.87 billion and a net profit of $0. The company's market cap is $92.72 billion.
According to TipRanks.com, Barclays analyst Steven Valiquette is currently ranked with 3 stars on a 0-5 stars ranking scale, with an average return of 2.6% and a 57.65% success rate.
Founded in 1792, Cigna Corporation (NYSE:CI) is a Connecticut-based global health services company, which provides insurance and related products and services. It operates through the following segments: Health Services, Integrated Medical, International Markets, and Group Disability and Other.